Mod GRF 1-29 & Ipamorelin Blend (10mg)

$81.00

Mod GRF 1-29 & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Mod GRF 1-29, a 29-residue GHRH analogue, with Ipamorelin, a 5-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1086

  • Product: Mod GRF 1-29 & Ipamorelin Blend

  • Listed quantity: 10 mg

  • Components: Mod GRF 1-29 and Ipamorelin

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: Mod-GRF-1-29-Ipamorelin-10mg Category:
Description

Mod GRF 1-29 & Ipamorelin Blend (10mg) for Laboratory Research

Mod GRF 1-29 & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratories investigating growth hormone regulatory signaling, receptor convergence, and neuroendocrine feedback pathways. The blend combines Mod GRF 1-29, a synthetic 29-residue GHRH analogue, with Ipamorelin, a synthetic 5-residue ghrelin mimetic. 1086

For laboratories looking to buy Mod GRF 1-29 & Ipamorelin Blend, this listing identifies a 10 mg quantity. Confirm the supplied material’s component ratio, salt state, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

Blend Product Information

Property Listing information
Product name Mod GRF 1-29 & Ipamorelin Blend
Listed quantity 10 mg
Components Mod GRF 1-29 and Ipamorelin
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the total quantity stated for this listing. It does not independently establish the amount of each component, net peptide content, or confirm that a particular quantity-assay method has been performed.

Reference Molecular Characteristics

The following characteristics describe the reference structures of the two components. They are not analytical confirmation of an individual commercial blend batch.

Component Reference molecular formula Approximate molecular weight PubChem identifier
Mod GRF 1-29 C₁₅₂H₂₅₂N₄₄O₄₂ 3367.9 g/mol 91976842
Ipamorelin C₃₈H₄₉N₉O₅ 711.9 g/mol 9831659

The molecular formulas and molecular weights are documented in the PubChem CJC-1295 Without DAC reference record and the PubChem Ipamorelin reference record. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1086

Mod GRF 1-29 is also known as CJC-1295 without DAC. It is a 29-amino-acid synthetic GHRH analogue. The sequence is documented in the Mod GRF 1-29 research summary and in the Mod GRF 1-29 research summary. 1086

GHRH and GHS-R1a Receptor Research

Mod GRF 1-29 binds selectively to the GHRH receptor, a class B G-protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary. Receptor engagement activates adenylyl cyclase, increasing intracellular cyclic AMP concentrations. 1086

Ipamorelin is a selective growth hormone secretagogue receptor agonist that activates the GHS-R1a receptor. Receptor engagement activates phospholipase C, increasing intracellular calcium concentrations. 1086

A review of CJC-1295 and Ipamorelin pharmacology describes CJC-1295 as a synthetic 30-amino-acid polypeptide engineering derivative of the native growth hormone-releasing hormone sequence. The same review notes that CJC-1295 activates the GHRH receptor, increasing intracellular cAMP and PKA activity, while Ipamorelin activates GHS-R1a, signaling through PLC, IP3, and calcium release. 1087

Read the CJC-1295 and Ipamorelin pharmacology review for the molecular mechanisms and evidence limitations.

Growth Hormone Pulsatility Research

A study evaluating a Modified GRF 1-29 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. The same study reported an approximately 28% increase in IGF-1 levels. 1086

A separate study of Ipamorelin reported that the peptide may enhance the peak synthesis of growth hormone by pituitary cells by more than 60-fold. The investigators reported that Ipamorelin may elevate growth hormone levels during a peak to around 80 mIU/L, equivalent to about 26.6 ng/mL. 1086

These findings apply to specific experimental protocols and do not establish that a commercial blend increases growth hormone in humans. 1086

Research Limitations

Published Mod GRF 1-29 and Ipamorelin research examines receptor signaling, cell-based assays, and animal models. It does not establish that a commercial blend increases growth hormone, improves body composition, supports recovery, or treats any condition. 1086

Published research also does not verify the identity, purity, component ratio, quantity, or biological activity of the commercial blend supplied with this listing.

Documentation and Batch Verification

Before selecting Mod GRF 1-29 & Ipamorelin Blend (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Component ratio and total blend quantity.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent component ratios, sequences, or molecular values.

For inquiries, provide “Mod GRF 1-29 & Ipamorelin Blend (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About Mod GRF 1-29 & Ipamorelin Blend (10mg)

What is Mod GRF 1-29 & Ipamorelin Blend?

It is a research blend combining Mod GRF 1-29, a synthetic 29-residue GHRH analogue, with Ipamorelin, a synthetic 5-residue ghrelin mimetic. 1086

What does the 10mg designation mean?

It is the total quantity stated for this listing. It does not describe the amount of each component, a concentration, or independently establish net peptide content.

Does this blend increase growth hormone?

Published research examines receptor signaling and growth hormone release in specific cell-based and animal models. It does not establish that a commercial blend increases growth hormone in humans. 1086

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial blend using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

Mod GRF 1-29 & Ipamorelin Blend (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery